2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review

M Fudim, WT Abraham, RS von Bardeleben… - Journal of the American …, 2021 - jacc.org
The regulatory landscape for device-based heart failure (HF) therapies has seen a major
shift in the last 7 years. In 2013, the US Food and Drug Administration released guidance for …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation

SD Anker, T Friede, RS von Bardeleben… - … England Journal of …, 2024 - Mass Medical Soc
Background Whether transcatheter mitral-valve repair improves outcomes in patients with
heart failure and functional mitral regurgitation is uncertain. Methods We conducted a …

3-year outcomes of transcatheter mitral valve repair in patients with heart failure

MJ Mack, JA Lindenfeld, WT Abraham, S Kar… - Journal of the American …, 2021 - jacc.org
Abstract Background In the COAPT (Cardiovascular Outcomes Assessment of the MitraClip
Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

New evidence supporting a novel conceptual framework for distinguishing proportionate and disproportionate functional mitral regurgitation

M Packer, PA Grayburn - JAMA cardiology, 2020 - jamanetwork.com
Importance Traditionally, physicians distinguished between mitral regurgitation (MR) as a
determinant of outcomes and MR as a biomarker of left-ventricular (LV) dysfunction by …

[HTML][HTML] Mitral valve transcatheter edge-to-edge repair

J Hausleiter, TJ Stocker, M Adamo, N Karam… - …, 2023 - ncbi.nlm.nih.gov
Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, results in reduced quality of life, heart failure, and increased mortality. Mitral valve …

Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve r egurgitaTiOn (GIOTTO): impact of valve disease aetiology and …

F Bedogni, A Popolo Rubbio, C Grasso… - European Journal of …, 2021 - Wiley Online Library
Abstract Aims The Italian Society of Interventional Cardiology (GIse) registry Of
Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO) was conceived in order to …

Myocardial work: methodology and clinical applications

K Papadopoulos, Ö Özden Tok, K Mitrousi, I Ikonomidis - Diagnostics, 2021 - mdpi.com
A precise and accurate assessment of left ventricular (LV) contractility is of utmost
importance in terms of prognosis in most cardiac pathologies. Given the limitations of …